We had also observed a positive clinical response to a decoction of L. indica leaves in an advanced-phase CML patient who was resistant to dasatinib, a second-generation BCR::ABL1 TKI. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.